BPG is committed to discovery and dissemination of knowledge
Welcome to the World Journal of Clinical Oncology

The World Journal of Clinical Oncology (WJCO) is a leading academic journal devoted to reporting the latest, cutting-edge research progress and findings of basic research and clinical practice in the field of oncology.  It was launched on November 10, 2010 and is published bimonthly (6 issues annually) by BPG, the world's leading professional clinical medical journal publishing company.

We encourage oncologists worldwide to submit manuscripts to the WJCO describing their original basic or clinical research findings that are of high academic value and which report new diagnostic techniques or summarize their treatment experiences.

The usual times related to all publication processes of the WJCO are as follows: (1) From manuscript receipt to peer-review: 2-4 weeks; (2) From initial manuscript acceptance, with revisions, to return of the revised manuscript from the authors: 4-5 weeks; (3) From return of the revised manuscript from the authors to final acceptance: 1-2 weeks; (4) From final acceptance to an article in press: 2 days; and (5) From article in press designation to formal release of the electronic version and all online documentation: 2-9 weeks. The WJCO’s acceptance rate: 55%. Submit here >>

2018 Published Issues
Editors-in-Chief
  • Godefridus J Peters, PhD, Professor, (E-mail:gj.peters@vumc.nl)Department of Medical Oncology, Cancer Center Amsterdam, VU University Medical Center, Amsterdam 1081 HV, Netherlands
Indexing/Abstracting
PubMed, PubMed Central, Scopus, and Emerging Sources Citation Index.
Journal Metrics
IPP (Impact per Publication) (2015): 3.306; SNIP (Source Normalized Impact per Paper) (2015): 1.241; CiteScore (2016): 4.00.
ISSN
2218-4333 (online)
Minireviews
Epidemic of non-alcoholic fatty liver disease and hepatocellular carcinoma 
Adnan Said, Aiman Ghufran 
World J Clin Oncol 8(6):429-436. Published online Dec 10, 2017. doi: 10.5306/wjco.v8.i6.429
Metronomic chemotherapy for non-metastatic triple negative breast cancer: Selection is the key 
Connie Rabanal, Rossana Ruiz, Silvia Neciosup, Henry Gomez 
World J Clin Oncol 8(6):437-446. Published online Dec 10, 2017. doi: 10.5306/wjco.v8.i6.437
With increasing trends of prostate cancer in the Saudi Arabia and Arab World: Should we start screening programs? 
Mostafa A Arafa, Danny M Rabah 
World J Clin Oncol 8(6):447-449. Published online Dec 10, 2017. doi: 10.5306/wjco.v8.i6.447